Kai has broad experience leading strategic engagements with clients across the life sciences industry, including big and small pharma/biopharma companies and investors. He has worked in all the major therapeutic areas, with a deep expertise in oncology / immuno-oncology, ophthalmology, neurology, and rare diseases. Kai works across the product and organizational life cycle, with a specific interest in business development and licensing support, asset and therapeutic area strategy, and growth strategy. In partnering with clients, Kai works to bring a content-driven strategic perspective, driving to grounded and actionable recommendations.
Kai has 5+ years of experience in life sciences-related research and consulting. Prior to joining ClearView, Kai studied the mechanisms of cell division at Yale as well as bone regeneration at UCSF. He received his B.S. in molecular and cell biology from Yale.
Debbi Amanti Belanger
Seth Berman
Steven Chao
Rishi Dalsania
David Gilman
Dean Griffiths
Kim Goh
Slater Hurst
Ketan Kapadia
Philip Kenner
Jessica Lee
Stuart MacGregor
Charles Mathews
David McClain
Kai-Ming Pu
Richard Mynahan
Kevin Richard
Derek Riesenberg
Mike Rizzo
Mike Roy
Bill Shew
Ryan Tubman
Sam Ulin
Debbie Zhuang
Jim Caruso
Sidnee Pinho
Kristine Hyde
Michael Agne
Jonathan Betts
Jonathan Hodgson
Owen Im
Jonny Juliano
Andrew Kang
Dave Konciak
Alexander Lehrman
Matthew Pfister
Olivia Piccione
Sarah Stapleton
Brian Quinn
Kelsey Yardumian
Jake Arakal
Kali Barnes
Jessica Berard
Beko Binder
Liang Dong
Maneesh Gujrati
Peter Goldman
Austin Hubbert
Joanna Lee
Angela Liu
Alec Marchuk
Matthew Murphy
Mike Murray
Soyeon Park
Shachi Patel
Cem Salfati
Sam Smith
Jim Duffy
Lainey Miller
Melanie Robinson